Tuesday, November 18, 2014

Equip Yourself for the Post of Assistant Drugs Inspector (50 Vacancies) at Staff Selection Commission With Career- Oriented Courses @ IBRI

A good opportunity  for the Pharmacy Students to enter into Govt.Sector thus don’t miss the chance Enhance Your Skills with Regulatory Affairs and Pharmavcovigilance which includes topics required for the Post and you would able to Grab the Job and Get success at all levels of Screening and Exam.

Post: Assistant Drugs Inspector
Department: In Central Drugs Standard Control Organisation(Dte. of Health Services)
No.of post: 50 (UR-25 / OBC- 13 /SC – 08 / ST 04)
Pay Scale: Rs.9300-34800 with Grade Pay of Rs. 4200/- (General Central Service, Group 'B', Non-Gazetted, Non-Ministerial).
Age Limit: Not exceeding 30 years ( Relaxable by 05 years for Government servants and for SC/ST/OBC as per standing orders of Government of India)
Essential Qualification: Degree in Pharmacy/Pharmaceutical Sciences or Medicine with Specialization in Clinical Pharmacology or Microbiology from a recognised University or equivalent.
Initial Posting: CDSCO (HQ) and its Zonal, Sub-Zonal and Port Offices in different cities with AISL

 Job Requirements: 
1. To assist in evaluation of safety, efficacy and quality of Drugs as per requirement of Drugs and Cosmetics Act, 1940.

2. To carry out field duty in assisting superior/Drugs Inspectors in taking out samples, enforcement activities like raids/inspections and launching prosecution etc.

3. To assist CDSCO officers in the mater of monitoring documentation.

4. To carry out duties as may be assigned under the Drugs and Cosmetics Act and Rules framed there under.

    

Sunday, November 2, 2014

PGI Pharma centre to hold meet on July 2

CHANDIGARH: The pharmacovigilance centre and regional training and resource centre, PGI, would organizing Indian Pharmacopoeia Commission (IPC) and WHO meeting of coordinators on July 2 in Kasauli.

The fifth training programme would be held under the aegis of WHO, IPC and the ministry of health and family welfare, Central government.

The meeting would focus over various aspects of pharmacovigilance, including quality and completeness of reports, causality assessment. Drugs of current interest in pharmacovigilance would be emphasized over. Measures to be taken for increasing the reporting of adverse drug reactions would be discussed.

Further, the meeting would provide a platform to participants for exchanging their experiences and ideas for the success of the pharmacovigilance programme.

IBRI NOIDA